Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sperling Medical Group is a specialized healthcare provider focused on precision diagnostics and minimally invasive treatments using advanced imaging technology. Led by Dr. Dan Sperling, the group is a pioneer in MRI-guided focal laser ablation (FLA) for prostate cancer and MRI-guided focused ultrasound (MRgFUS) for neurological conditions like essential tremor. The practice emphasizes "image-to-treatment" workflows that minimize side effects compared to traditional surgery or radiation. With locations in Florida and New York, they provide cutting-edge radiological services and personalized patient care. The group is particularly noted for its work in focal therapy, which aims to treat only the tumor while preserving healthy tissue and function.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sperling Medical Group.